In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Apr-09-21 |
| 10-Q | 10-Q | | 10-Q | 10-Q | | |
Assets | | | | | | | |
Current assets: | | | | | | | |
Cash in escrow | | | | | | | |
Prepaid expense | 0.1 | 0.1 | | 0.1 | 0.1 | | |
Marketable securities held in trust account | 123.2 | 120.6 | | 115.2 | 115.0 | | |
Total current assets | 123.4 | 120.7 | | 115.4 | 115.3 | | |
Total assets | 123.4 | 120.7 | | 115.4 | 115.3 | | |
|
Liabilities and stockholders’ deficit | | | | | | | |
Current liabilities: | | | | | | | |
Accrued expenses | 2.9 | 2.9 | | 2.9 | 2.9 | | |
Promissory note – related party | 3.9 | 2.7 | | | | | |
Due to related parties | 0.2 | 0.2 | | | | | |
Deferred underwriting commissions | 2.9 | 2.9 | | 2.9 | 2.9 | | |
Total current liabilities | 7.2 | 5.9 | | 3.0 | 2.9 | | |
Total liabilities | 7.2 | 5.9 | | 3.0 | 2.9 | | |
|
Commitment and contingencies (Note 6) | | | | | | | |
Ordinary shares subject to possible redemption, 11,500,000 and 11,500,000 shares at redemption value of $10.72 and $10.28 per share at June 30, 2023 and December 31, 2022, respectively | 123.2 | 120.6 | | 115.2 | 115.0 | | |
|
Stockholders’ deficit: | | | | | | | |
Ordinary shares | 0.0 | 0.0 | | 0.0 | 0.0 | | |
|
Additional paid-in capital | | | | | | | |
Accumulated deficit | -7.0 | -5.8 | | -2.8 | -2.6 | | |
Total stockholders’ deficit | -7.0 | -5.8 | | -2.8 | -2.6 | | |
Total liabilities and stockholders’ deficit | 123.4 | 120.7 | | 115.4 | 115.3 | | |